MPI is a Danish pharmacodiagnostic company with proprietary pivotal technology (DNA microarray, qPCR based) which is Universally Applicable to any drug and any disease to determine Drug Response Prediction (DRP).
DRUG TARGETING
|
PHARMACO Dx
|
- Speed up Drug Development
- Save millions on development cost
- Increase drug development success
- Maximize on-patent sales period
|
|
DNA MICROARRAY SERVICES
For your gene / drug discovery needs MPI offers highest quality, bioinformatics expertise, turn-around time and cost-effectiveness for your research projects.
|
|
Announcements
MPI publishes Exercise Response Predictor
MPI, together with... Read more
New CEO as of January 1, 2010.
MPI is proud to announce... Read more Blind clinical validation of drug response predictor
... Read more
|